Mercer Global Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3M | Sell |
5,710
-2,720
| -32% | -$1.43M | 0.01% | 705 |
|
|
2025
Q1 | $5.35M | Sell |
8,430
-14,954
| -64% | -$9.48M | 0.01% | 522 |
|
|
2024
Q4 | $16.7M | Sell |
23,384
-2,389
| -9% | -$1.7M | 0.04% | 250 |
|
|
2024
Q3 | $27M | Buy |
25,773
+1,454
| +6% | +$1.52M | 0.06% | 162 |
|
|
2024
Q2 | $25.5M | Buy |
24,319
+1,122
| +5% | +$1.18M | 0.07% | 164 |
|
|
2024
Q1 | $22.3M | Buy |
23,197
+1,328
| +6% | +$1.28M | 0.06% | 183 |
|
|
2023
Q4 | $19.2M | Buy |
21,869
+869
| +4% | +$763K | 0.06% | 201 |
|
|
2023
Q3 | $17.3M | Buy |
21,000
+1,713
| +9% | +$1.41M | 0.07% | 187 |
|
|
2023
Q2 | $13.9M | Buy |
19,287
+883
| +5% | +$634K | 0.06% | 226 |
|
|
2023
Q1 | $15.1M | Sell |
18,404
-489
| -3% | -$402K | 0.07% | 203 |
|
|
2022
Q4 | $13.6M | Buy |
18,893
+1,218
| +7% | +$879K | 0.07% | 210 |
|
|
2022
Q3 | $12.2M | Buy |
17,675
+1,480
| +9% | +$1.02M | 0.07% | 201 |
|
|
2022
Q2 | $9.57M | Buy |
16,195
+2,806
| +21% | +$1.66M | 0.06% | 233 |
|
|
2022
Q1 | $9.35M | Buy |
13,389
+5,423
| +68% | +$3.79M | 0.06% | 238 |
|
|
2021
Q4 | $5.03M | Buy |
7,966
+4,264
| +115% | +$2.69M | 0.03% | 370 |
|
|
2021
Q3 | $2.24M | Buy |
3,702
+87
| +2% | +$52.6K | 0.02% | 570 |
|
|
2021
Q2 | $2.02M | Sell |
3,615
-2,447
| -40% | -$1.37M | 0.02% | 566 |
|
|
2021
Q1 | $2.87M | Buy |
6,062
+1,710
| +39% | +$809K | 0.03% | 426 |
|
|
2020
Q4 | $2.1M | Buy |
4,352
+1,788
| +70% | +$864K | 0.03% | 410 |
|
|
2020
Q3 | $1.44M | Buy |
2,564
+1,758
| +218% | +$984K | 0.02% | 464 |
|
|
2020
Q2 | $503K | Buy |
806
+6
| +0.8% | +$3.74K | 0.01% | 681 |
|
|
2020
Q1 | $391K | Buy |
800
+84
| +12% | +$41.1K | 0.01% | 737 |
|
|
2019
Q4 | $269K | Buy |
+716
| New | +$269K | 0.01% | 958 |
|